C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 99 filers reported holding C4 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,886 | -32.4% | 13,917 | 0.0% | 0.00% | – |
| Q2 2023 | $38,272 | -4.7% | 13,917 | +8.8% | 0.00% | – |
| Q1 2023 | $40,170 | -40.1% | 12,793 | +12.6% | 0.00% | – |
| Q4 2022 | $67,054 | -68.4% | 11,365 | +73.0% | 0.00% | – |
| Q4 2021 | $212,000 | -41.4% | 6,570 | -18.9% | 0.00% | – |
| Q3 2021 | $362,000 | +74.0% | 8,106 | +47.2% | 0.00% | – |
| Q2 2021 | $208,000 | – | 5,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOR CAPITAL ADVISORS, INC. | 75,794 | $428,236 | 0.08% |